Poster Presentation 40th Annual Lorne Genome Conference 2019

USP48 directly antagonises BRCA1-driven histone ubiquitination to regulate chromatin remodelling in response to DNA damage. (#263)

Michael Uckelmann 1 2 , Ruth Densham 3 , Alexander Fish 1 , Chen Davidovich 2 , Joanne Morris 3 , Titia Sixma 1
  1. The Netherlands Cancer Institute - NKI, Amsterdam, the Netherlands
  2. Biochemistry and Molecular Biology, Monash University, Melbourne, Victoria, Australia
  3. University of Birmingham, Birmingham, England

The DNA damage response, chromatin remodelling and transcriptional regulation are partially interdependent pathways that share a common feature, in that they are all regulated by posttranslational modifications of histones. Lysine-specific ubiquitination of histone H2A has been shown to be involved in these pathways. H2A can get ubiquitinated on three independent ubiquitination sites, by three different E3 ligases: BRCA1-BARD1, RNF2 — in a PRC1 complex — and RNF168. The ubiquitination status on these three sites has distinct signalling outcomes and represents a fine balance between the activities of ubiquitinating and deubiquitinating enzymes (DUBs).Yet, the lysine-specificity of H2A DUBs and the biological implications of specific H2A ubiquitination remained elusive.

Screening for H2A-specific DUBs, we found USP48 to be a DUB specific for the BRCA1-BARD1 induced H2A ubiquitination mark. Detailed biochemical analysis revealed a curious mode of action, where USP48 only efficiently cleaves BRCA1-ubiquitinated H2A when activated by an auxiliary ubiquitin on an adjacent lysine. Further analysis indicates that this auxiliary ubiquitin can be placed on the PRC1 target-site to activate cleavage of the BRCA1 target-site. These observation implies that USP48 antagonises BRCA1 in a PRC1-dependent manner and thus suggesting a potential crosstalk between these pathways.

Knockout-rescue experiments in cells established USP48 as a direct antagonist of BRCA1 signalling in the DNA damage response. Specifically, loss of USP48 disrupts the balance of repair pathway choice, promoting the use of error-prone single strand-annealing pathways. This is due to extended DNA-end resection, driven by BRCA1-BARD1 ubiquitin ligase activity and SMARCAD1-dependent chromatin remodelling, upon USP48 loss. DNA repair through single-strand annealing leads to large chromosomal deletions, which potentially implies a function of USP48-driven repair pathway choice in cancer development.  

Collectively, our findings indicate that USP48 is a direct antagonist of BRCA1 ubiquitination activity that acts in concert with SMARCAD1-dependent chromatin remodelling and PRC1-catalysed histone ubiquitination.